Skip to main content

Table 2 Treatment characteristics of 84 lesions

From: Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma

Variables Number of patients (%)
Previous treatment (n = 77)
 TACE 41 (53.2)
 TACE + RFA 17 (22.1)
 TACE + PEI 3 (3.9)
 TACE + RFA + PEI 1 (1.3)
 TACE + Resection 6 (7.8)
 TACE + Resection + RFA 6 (7.8)
 TACE + Resection + PEI 1 (1.3)
 TACE + Resection + RFA + PEI 1 (1.3)
 RFA 1 (1.3)
Radiation dose
 35 Gy/10 fractions 7 (8.3)
 40 Gy/10 fractions 27 (32.2)
 50 Gy/10 fractions 50 (59.5)
Radiotherapy plan
 Three-dimensional conformal radiotherapy 80 (95.2)
 Volumetric-modulated arc therapy 4 (4.8)
Respiratory-gated beam delivery
 Yes 79 (94.0)
 No 5 (6.0)
  1. TACE transarterial chemoembolization, RFA radiofrequency ablation, PEI percutaneous ethanol injection